Your browser doesn't support javascript.
loading
Exhaled breath condensate profiles of U.S. Navy divers following prolonged hyperbaric oxygen (HBO) and nitrogen-oxygen (Nitrox) chamber exposures.
Fothergill, David M; Borras, Eva; McCartney, Mitchell M; Schelegle, Edward S; Davis, Cristina E.
Afiliación
  • Fothergill DM; Command Suite, Naval Submarine Medical Research Laboratory, Groton, CT, 06349-5900, United States of America.
  • Borras E; Mechanical and Aerospace Engineering, One Shields Avenue, University of California, Davis, Davis, CA, United States of America.
  • McCartney MM; UC Davis Lung Center, One Shields Avenue, University of California, Davis, Davis, CA, United States of America.
  • Schelegle ES; Mechanical and Aerospace Engineering, One Shields Avenue, University of California, Davis, Davis, CA, United States of America.
  • Davis CE; UC Davis Lung Center, One Shields Avenue, University of California, Davis, Davis, CA, United States of America.
J Breath Res ; 17(3)2023 06 12.
Article en En | MEDLINE | ID: mdl-37207635
Prolonged exposure to hyperbaric hyperoxia can lead to pulmonary oxygen toxicity (PO2tox). PO2tox is a mission limiting factor for special operations forces divers using closed-circuit rebreathing apparatus and a potential side effect for patients undergoing hyperbaric oxygen (HBO) treatment. In this study, we aim to determine if there is a specific breath profile of compounds in exhaled breath condensate (EBC) that is indicative of the early stages of pulmonary hyperoxic stress/PO2tox. Using a double-blind, randomized 'sham' controlled, cross-over design 14 U.S. Navy trained diver volunteers breathed two different gas mixtures at an ambient pressure of 2 ATA (33 fsw, 10 msw) for 6.5 h. One test gas consisted of 100% O2(HBO) and the other was a gas mixture containing 30.6% O2with the balance N2(Nitrox). The high O2stress dive (HBO) and low O2stress dive (Nitrox) were separated by at least seven days and were conducted dry and at rest inside a hyperbaric chamber. EBC samples were taken immediately before and after each dive and subsequently underwent a targeted and untargeted metabolomics analysis using liquid chromatography coupled to mass spectrometry (LC-MS). Following the HBO dive, 10 out of 14 subjects reported symptoms of the early stages of PO2tox and one subject terminated the dive early due to severe symptoms of PO2tox. No symptoms of PO2tox were reported following the nitrox dive. A partial least-squares discriminant analysis of the normalized (relative to pre-dive) untargeted data gave good classification abilities between the HBO and nitrox EBC with an AUC of 0.99 (±2%) and sensitivity and specificity of 0.93 (±10%) and 0.94 (±10%), respectively. The resulting classifications identified specific biomarkers that included human metabolites and lipids and their derivatives from different metabolic pathways that may explain metabolomic changes resulting from prolonged HBO exposure.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hiperoxia / Oxigenoterapia Hiperbárica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Breath Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hiperoxia / Oxigenoterapia Hiperbárica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Breath Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos